文献速递前列腺增生与排尿功能障碍泌尿系感染

前列腺MRI诊断「前列腺炎」的临床与病理相关性

The Clinical and Pathologic Relevance of a Prostate MRI Diagnosis of "Prostatitis".
PubMed 文献 · Urology · 2021-02-01

回顾性分析2016-2017年接受前列腺mpMRI的患者,按放射报告是否出现「前列腺炎/炎症」分为两组,比较临床症状、用药与病理炎症。结果显示影像「前列腺炎」与中重度下尿路症状无关,仅与活检病理炎症相关,提示多属NIH IV型,患者可被告知无需进一步检查。

要点

  • 影像报告「前列腺炎」与症状性下尿路症状无相关性。
  • 影像「前列腺炎」组活检病理炎症更常见(57% vs 43%)。
  • 此类患者可被告知无需因影像「炎症」进一步检查。

核心结论

  • mpMRI提示的前列腺炎可能对应NIH IV型前列腺炎,但与I、II、III型前列腺炎及症状性LUTS无相关性,患者应被安抚无需进一步检查。

研究设计与样本

  • 比较年龄、PSA、活检/干预史、真实LUTS、疼痛、泌尿用药、前列腺体积、PIRADS评分及病理炎症。
  • 二分类变量用卡方检验,连续变量用t检验。

主要发现

  • 骨盆疼痛、排尿困难或尿液炎症表现在两组均少见。

关键数值与推荐

  • 中重度LUTS定义:医生描述或IPSS 8-19及20+。

临床怎么用

  • 影像报告「前列腺炎/炎症」不应作为进一步泌尿专科检查或治疗LUTS的依据。
  • 可向患者说明该影像发现多为NIH IV型,与症状性前列腺炎无明确关联,减轻焦虑。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the relationship between magnetic resonance imaging evidence of prostatitis with clinical symptomatology. Non-malignant abnormalities in peripheral zone are common in prostate multiparametric prostate magnetic resonance imaging (mpMRI). These findings are sometimes reported as "prostatitis" or "inflammation" and lead to patient anxiety and urologic referral. METHODS: Retrospective review of patients undergoing prostate mpMRI (2016-2017) was performed. Two cohort groups based on the presence of "prostatitis" or "inflammation" in the radiology report were identified. Clinical characteristics included age, prostate specific antigen, biopsy/intervention history, true lower urinary tract symptoms (LUTS), pain, use of urologic medications, prostate volume, and PIRADS score. Pathologic finding of inflammation was recorded. Groups were compared using chi-square for dichotomous variables and t-tests for continuous variables. RESULTS: One hundred and four patients were identified with "prostatitis/inflammation" and 273 without. Report of LUTS was high in both groups (58% and 62% for prostatitis and no prostatitis respectively, P= .49), though report of moderate/severe LUTS (physician description or IPSS of 8-19 and 20+) was more common in the no prostatitis group (7% vs 18%, P= .008). Use of urologic medication was similar between the 2 groups (31% and 37% for prostatitis and no prostatitis respectively, P = .23). Biopsy finding of inflammation was more common in the prostatitis group (57% vs 43% P = .027). Reports of pelvic pain, dysuria, or urinary findings of inflammation were uncommon in both groups. CONCLUSION: While mpMRI findings of prostatitis may indicate NIH Category IV prostatitis, there is no evidence of correlation with categories I, II or III prostatitis nor with symptomatic LUTS, and patients should be reassured that further investigation is not warranted.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Hemal S, Thomas L, Shoskes D, et al. The Clinical and Pathologic Relevance of a Prostate MRI Diagnosis of "Prostatitis". Urology. 2021. PMID: 33539898. doi:10.1016/j.urology.2021.01.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。